Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Moy-Fincher Medical Group.
Recruitment status was:  Not yet recruiting
Information provided by:
Moy-Fincher Medical Group Identifier:
First received: August 29, 2009
Last updated: September 13, 2009
Last verified: September 2009
The purpose of this study is to determine if fractional carbon dioxide laser treatment of a fresh wound at the time of surgery, decreases scar formation. Scar revision is commonly done at 6-10 weeks following surgery. Therefore, it may be more beneficial, for both the patient and physician, to perform scar revision at the time of surgery.

Condition Intervention
Device: Lumenis fractional carbon dioxide laser

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effects of Fractional CO2 Resurfacing Prior to Complex Wound Closure

Resource links provided by NLM:

Further study details as provided by Moy-Fincher Medical Group:

Primary Outcome Measures:
  • Evidence of scar improvement as assessed by blinded-observer and patient ratings. [ Time Frame: At two and six weeks following the procedure ]

Estimated Enrollment: 10
Study Start Date: October 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Half of each subject's wound will not be treated.
Experimental: Laser resurfacing
Half of each subject's wound will be treated with a fractional CO2 laser.
Device: Lumenis fractional carbon dioxide laser
intra-operative laser resurfacing at time of wound closure
Other Name: Lumenis


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Undergoing skin cancer surgery
  • Will have a straight-line incision
  • Fluent in English
  • Must reside in the Los Angeles vicinity for the duration of the study

Exclusion Criteria:

  • Non-English speakers
  • Pregnant or cognitively impaired subjects
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00969475

Contact: Telia DeBoyes

United States, California
Moy-Fincher Medical Group Not yet recruiting
Los Angeles, California, United States, 90095
Contact    310-794-7422      
Principal Investigator: David Ozog, MD         
Sub-Investigator: Edgar Fincher, MD         
Sub-Investigator: Ronald Moy, MD         
Sub-Investigator: Lisa Chipps, MD         
Sponsors and Collaborators
Moy-Fincher Medical Group
Principal Investigator: David Ozog, MD Moy-Fincher Medical Group
  More Information

Responsible Party: Ronald Moy, MD, Moy-Fincher Medical Group Identifier: NCT00969475     History of Changes
Other Study ID Numbers: MF-01
Study First Received: August 29, 2009
Last Updated: September 13, 2009

Keywords provided by Moy-Fincher Medical Group:
scar revision
fractional carbon dioxide laser processed this record on April 28, 2017